In cancer patient during or following oncologic therapies with respiratory symptoms and pulmonary pathology at chest CT the differential diagnosis includes infection, therapy-induced disease and tumour progression. Although CT morphology may be typical or even pathognomonic in some conditions the diagnosis is usually made by a synopsis of imaging, clinical and laboratory features. Close communication with referring colleagues and a good knowledge of potential side effects of therapeutic concepts, their time course and CT morphology is crucial in the differential diagnosis. This review describes a personal approach to the radiological diagnosis of therapy-induced pulmonary abnormalities in cancer patients.
CITATION STYLE
Diederich, S. (2016, April 11). Chest CT for suspected pulmonary complications of oncologic therapies: How i review and report. Cancer Imaging. BioMed Central Ltd. https://doi.org/10.1186/s40644-016-0066-4
Mendeley helps you to discover research relevant for your work.